The high rate of de novo graft carcinomas in renal transplant recipients

American Journal of Nephrology

Volumn 37, Issue 2, 2013, Pages 91-96

  Viart, Ludovic ^a   Surga, Nicolas ^a   Collon, Sylvie ^b   Jaureguy, Maité ^a   Elalouf, Vincent ^d   Tillou, Xavier ^c  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b Orthopedic Surgery Department   (France)

^c CHU CÔTE DE NACRE   (France)

^d Urology and Transplantation University Hospital Caen CHU Cote de Nacre ^*  (France)

Author keywords

Graft tumor; Kidney transplantation

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; KIDNEY CARCINOMA; KIDNEY GRAFT; KIDNEY GRAFT CARCINOMA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEPHRON SPARING SURGERY; OUTCOME ASSESSMENT; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE DATABASE; SEX RATIO; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; TUMOR VOLUME; URETER CARCINOMA;

EID: 84873038040     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000346624     Document Type: Article

References (24)

1. Birkeland SA, Lokkegaard H, Storm HH: Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000; 355: 1886-1887.
2. Tsaur I, Karalis A, Probst M, et al: Development of urological cancers in renal transplant recipients: 30-year experience at the Frankfurt Transplant Center. Cancer Sci 2010; 101: 2430-2435.
3. Birkeland SA: De novo cancers complicating renal transplantation: experience in the Nordic countries. Ann Transplant 1997; 2: 22-26.
4. Lutz J, Heemann U: Tumours after kidney transplantation. Curr Opin Urol 2003; 13: 105-109.
5. Penn I: Primary kidney tumors before and after renal transplantation. Transplantation 1995; 59: 480-485.
6. Tillou X, Doerfler A, Collon S, et al: De novo kidney graft tumors: results from a multicentric retrospective national study. Am J Transplant 2012; 12: 3308-3315.
7. Dantal J, Pohanka E: Malignancies in renal transplantation: an unmet medical need. Nephrol Dial Transplant 2007; 22(suppl 1):i4-i10.
8. Brown KM, Kondeatis E, Vaughan RW, et al: Influence of donor C3 allotype on late renal transplantation outcome. N Engl J Med 2006; 354: 2014-2023.
9. Elkentaoui H, Robert G, Pasticier G, et al: Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux. Urology 2010; 75: 126-132.
10. Doublet JD, Peraldi MN, Gattegno B, Thibault P, Sraer JD: Renal cell carcinoma of native kidneys: prospective study of 129 renal transplant patients. J Urol 1997; 158: 42-44.
11. Melchior S, Franzaring L, Shardan A, et al: Urological de novo malignancy after kidney transplantation: a case for the urologist. J Urol 2011; 185: 428-432.
12. Barama A, St-Louis G, Nicolet V, Hadjeres R, Daloze P: Renal cell carcinoma in kidney allografts: a case series from a single center. Am J Transplant 2005; 5: 3015-3018.
13. Baughman SM, Sexton WJ, Glanton CW, Dalrymple NC, Bishoff JT: Computerized tomography-guided radiofrequency ablation of a renal cell carcinoma within a renal allograft. J Urol 2004; 172: 1262-1263.
14. Wunderlich H, Wilhelm S, Reichelt O, Zermann DH, Borner R, Schubert J: Renal cell carcinoma in renal graft recipients and donors: incidence and consequence. Urol Int 2001; 67: 24-27.
15. Park KI, Inoue H, Kim CJ, Tomoyoshi T: Nephron-sparing surgery for de novo renal cell carcinoma in an allograft kidney: a case report. Int J Urol 1997; 4: 611-614.
16. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9(suppl 3):S1-S155.
17. Hall EJ, Brenner DJ: Cancer risks from diagnostic radiology. Br J Radiol 2008; 81: 362-378.
18. Cherif M, Rouache L, Tapon E, Pfister C: Usefulness of an inline radiofrequency device in renal allograft preserving surgery. Transplantation 2007; 83: 522-523.
19. Greco AJ, Baluarte JH, Meyers KE, et al: Chromophobe renal cell carcinoma in a pediatric living-related kidney transplant recipient. Am J Kidney Dis 2005; 45:e105-e108.
20. Shingleton WB, Sewell PE: Percutaneous cryoablation of renal cell carcinoma in a transplanted kidney. BJU Int 2002; 90: 137-138.
21. Hetet JF, Rigaud J, Dorel-Le Theo M, Laute F, Karam G, Blanchet P: De novo tumours of renal transplants (in French). Ann Urol 2007; 41: 285-297.
22. Kalble T, Lucan M, Nicita G, Sells R, Burgos Revilla FJ, Wiesel M: EAU guidelines on renal transplantation. Eur Urol 2005; 47: 156-166.
23. Tremblay F, Fernandes M, Habbab F, deB Edwardes MD, Loertscher R, Meterissian S: Malignancy after renal transplantation: incidence and role of type of immunosuppression. Ann Surg Oncol 2002; 9: 785-788.
24. Geissler EK, Schlitt HJ: The potential benefits of rapamycin on renal function, tolerance, fibrosis, and malignancy following transplantation. Kidney Int 2010; 78: 1075-1079.